The room was filled with the sound of pens clicking and notes being written as attendees listened to various faculty members presenting the latest advancements in the treatment, diagnosis, and ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that it will share results from the DEFINE-HT study in a late-breaking oral presentation at the ...
Presentation: First Report of Phase Ib/2a Study Evaluating Safety and Early Efficacy of TN-201, an Adeno-Associated Virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback